Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for ...
RIVERSIDE, N.J. (WPVI) -- A multiple sclerosis diagnosis used to mean a future of disability. But now, a revolution in medications allows MS patients to pursue their dreams. Those medications are ...
Several disease-modifying therapies for MS were associated with increased risks for urinary tract infections and urosepsis, ...
Living with multiple sclerosis (MS) often means managing a mix of symptoms that affect daily life, including fatigue, mobility challenges, pain, and changes in strength and endurance. Body weight can ...
Cantex and Headlamp Health are teaming up to accelerate the development of azeliragon for severe depression and fatigue in MS ...
Anti-CD20 therapies and S1P receptor modulators seem to be equally effective for most people with late-onset MS, a real-world ...
A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton’s tyrosine kinase inhibitor (a group of drugs originally developed to treat lymphomas and related blood disorders) ...
MS is a chronic, immune-mediated disease affecting the central nervous system, with no known cure and varying levels of impact on individuals. Over 20 FDA-approved disease-modifying therapies exist, ...
Please provide your email address to receive an email when new articles are posted on . Children presented with unique MS symptoms, while adolescents’ issues aligned more with adults. Nearly half of ...
Hosted on MSN
Women Less Likely to Get MS Meds Than Men
Women with MS are 8% less likely than their male peers to get drugs that could slow disease progression and delay disability Fears that the meds might interfere with pregnancy could be one reason, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results